Mizolastine is an orally active, high affinity, and specific peripheral histamine H1 receptor antagonist. It effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC, and can be used in studies of allergic rhinitis and chronic idiopathic urticaria.
- Specific peripheral histamine H1 receptor antagonist
- Inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC
- Suitable for research on allergic rhinitis
- Suitable for research on chronic idiopathic urticaria
- High purity of 99.8%